Nurix Therapeutics | 8-K: Current report
Apr 12 17:14 ET
Nurix Therapeutics | 424B5: Prospectus
Apr 12 17:13 ET
Nurix Therapeutics | 424B5: Prospectus
Apr 11 16:11 ET
Nurix Therapeutics | 10-Q: Quarterly report
Apr 10 07:07 ET
Nurix Therapeutics | 8-K: Current report
Apr 10 07:07 ET
Nurix Therapeutics | 8-K: Current report
Apr 9 13:20 ET
Nurix Therapeutics | ARS: Annual Report to Security Holders
Mar 27 07:08 ET
Nurix Therapeutics | DEFA14A: Others
Mar 27 07:04 ET
Nurix Therapeutics | DEF 14A: Definitive information statements
Mar 27 07:04 ET
Nurix Therapeutics | 8-K: Current report
Mar 11 07:06 ET
Nurix Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer van Houte Hans
Feb 16 19:22 ET
Nurix Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Feb 16 16:29 ET
Nurix Therapeutics | 10-K: Annual report
Feb 15 22:20 ET
Nurix Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Feb 15 16:53 ET
Nurix Therapeutics | 8-K: Current report
Feb 15 16:03 ET
Nurix Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer van Houte Hans
Feb 15 07:27 ET
Nurix Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Ring Christine
Feb 15 07:27 ET
Nurix Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hansen Gwenn
Feb 15 07:27 ET
Nurix Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer SANDS ARTHUR T
Feb 15 07:27 ET
Nurix Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baker Bros. Advisors LP(9.99%),Baker Bros. Advisors (GP) LLC(9.99%), etc.
Feb 14 17:46 ET
No Data
No Data